Abstract
The research outputs featured in this abridged selection provide evidence regarding the burdent of osteoarthritis in the NZ adult population, and the effectiveness, cost-effectiveness, and stakeholder acceptability of treatments for osteoarthritis.
The evidence we provide ranges from primary randomised controlled trials, clinical trials, systematic literature reviews, health economics and stakeholder preferences research, to computer simulation modelling using our bespoke NZ-MOA state transition microsimulation model of the progression, costs and consequences of osteoarthritis and its treatments in the NZ population.
This evidence culminates in a Policy Brief, that recommends actions for the management of osteoarthritis in the NZ public health system.